Centogene Investor
CENTOGENE provides methods and technology for human genetics analysis.
Industry:
Mitochondrial Genetics
Technology:
Pregnancy biomarkers, Biomarkers of Female Cancers
Funding Status:
Series A
Estimated Revenue:
$50M to $100M
Investors Number:
4
Headquarters:
Rostock, Mecklenburg-Vorpommern, Germany
Total Funding:
$29 M
Founded Date:
2016
Last Funding Type:
Grant